Halperin SA - Search Results

1

Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture.

Halperin SA, Nestruck AC, Eastwood BJ. Halperin SA, et al. Vaccine. 1998 Aug;16(13):1331-5. doi: 10.1016/s0264-410x(98)00011-5. Vaccine. 1998. PMID: 9682398 Clinical Trial.

2

Immune responses to pertussis vaccines concurrently administered with viral vaccines.

Halperin SA, Eastwood BJ, Langley JM. Halperin SA, et al. Ann N Y Acad Sci. 1995 May 31;754:89-96. doi: 10.1111/j.1749-6632.1995.tb44441.x. Ann N Y Acad Sci. 1995. PMID: 7625684 Clinical Trial. No abstract available.

3

Immunogenicity of a five-component acellular pertussis vaccine in infants and young children.

Halperin SA, Barreto L, Friesen B, Meekison W. Halperin SA, et al. Arch Pediatr Adolesc Med. 1994 May;148(5):495-502. doi: 10.1001/archpedi.1994.02170050053010. Arch Pediatr Adolesc Med. 1994. PMID: 7910089 Clinical Trial.

4

Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.

Halperin SA, Barreto L, Eastwood BJ, Law B, Roberts EA. Halperin SA, et al. Arch Pediatr Adolesc Med. 1994 Nov;148(11):1220-4. doi: 10.1001/archpedi.1994.02170110106025. Arch Pediatr Adolesc Med. 1994. PMID: 7921131 Clinical Trial. No abstract available.

5

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R, et al. Halperin SA, et al. Scand J Infect Dis. 1995;27(3):279-87. doi: 10.3109/00365549509019022. Scand J Infect Dis. 1995. PMID: 8539554 Clinical Trial.

6

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.

Halperin SA, Mills E, Barreto L, Pim C, Eastwood BJ. Halperin SA, et al. Pediatr Infect Dis J. 1995 Sep;14(9):792-7. doi: 10.1097/00006454-199509000-00012. Pediatr Infect Dis J. 1995. PMID: 8559630 Clinical Trial.

7

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life.

Halperin SA, Eastwood BJ, Barreto L, Friesen B, Medd L, Meekison W, Guasparini R. Halperin SA, et al. Vaccine. 1996 Jun;14(8):767-72. doi: 10.1016/0264-410x(95)00250-5. Vaccine. 1996. PMID: 8817823 Clinical Trial.

8

Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.

Halperin SA, Langley JM, Eastwood BJ. Halperin SA, et al. Clin Infect Dis. 1996 Jan;22(1):59-62. doi: 10.1093/clinids/22.1.59. Clin Infect Dis. 1996. PMID: 8824967 Clinical Trial.

9

Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.

Halperin SA, Davies HD, Barreto L, Guasparini R, Meekison W, Humphreys G, Eastwood BJ. Halperin SA, et al. J Pediatr. 1997 Apr;130(4):525-31. doi: 10.1016/s0022-3476(97)70233-6. J Pediatr. 1997. PMID: 9108847 Clinical Trial.

10

Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine.

Halperin SA, Barreto L, Eastwood BJ, Medd L, Guasparini R, Mills E. Halperin SA, et al. Vaccine. 1997 Feb;15(3):295-300. doi: 10.1016/s0264-410x(96)00177-6. Vaccine. 1997. PMID: 9139489 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters